Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
评估ionis pharmaceuticals：来自6名金融分析师的见解。
6 analysts have shared their evaluations of Ionis Pharmaceuticals (NASDAQ:IONS) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三个月，有6位分析师对Ionis Pharmaceuticals(NASDAQ:IONS)进行了评估，表达了看好和看淡的观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.0, a high estimate of $82.00, and a low estimate of $53.00. A 0.61% drop is evident in the current average compared to the previous average price target of $65.40.
分析师分析的12个月价格目标提供了洞察力，平均目标为65.0美元，最高估值为82.00美元，最低估值为53.00美元。当前平均估值相比之前平均估值65.40美元下降了0.61%。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
The analysis of recent analyst actions...
最近的分析师...
登录免费看全文
登录/注册